Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
批准号:
10445486
负责人:
Azra Bihorac
金额:
$55.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-03-01 至 2026-05-31
关键词:
AddressAdoptedAlgorithmsAmericanArtificial IntelligenceArtificial Intelligence platformBehavioralBenchmarkingBridge to Artificial IntelligenceClinicalClinical ResearchClinical TrialsCognitiveCollaborationsComplicationComputing MethodologiesCritical CareDataData PoolingData SetEarly InterventionEnvironmentEthicsEvaluationFloridaFoundationsFundingGenerationsHealthHospital CostsHospitalizationHospitalsHumanInformaticsInfrastructureInstitutionIntelligenceInvestmentsLegal patentMachine LearningMedicalMindMissionModelingOperative Surgical ProceduresPatient CarePatient-Focused OutcomesPatientsPerformancePerioperative CarePhysiciansPhysiologicalPopulation HeterogeneityPostoperative ComplicationsPrevention strategyPrivacyProcessProductivityPsyche structurePublic HealthPublicationsReproducibilityResearchRiskRisk AssessmentScienceSystemTechnologyTestingTimeTrainingTrustUnited StatesUnited States National Institutes of HealthUniversitiesValidationWorkadvanced diseaseclinical implementationcollaborative approachcomputerized toolsdata sharingdata streamsdisease diagnosisdistributed dataeffectiveness evaluationfederated learninghigh riskhuman centered computingimprovedinnovationinteroperabilitymachine learning algorithmmultimodal datamultimodalitynoveloperationpreferenceprivacy preservationprogramsprospectiveprospective testsocial health determinantssuccesssurgical risktheoriestooltrustworthinessusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
In the United States, the average American can expect to undergo seven surgical operations during a lifetime.
Each year 150,000 surgical patients die, and 1.5 million develop a complication after surgery. Progress in
medical Artificial Intelligence (AI) remains halted by limited datasets and models with insufficient interpretability,
transparency, fairness, and reproducibility that are difficult to implement and share across institutions. In the
previous funding period, in addition to 98 publications and 3 patents, a real-time intelligent surgical risk
assessment system was successfully implemented at University of Florida. The overall objective of this
renewal application is to develop a new conceptual framework for “Explainable, Fair, Reproducible, and
Collaborative Medical AI” to provide a foundation for clinical implementation at scale. It will leverage the
OneFlorida, a large clinical consortium of 22 hospitals serving 10 million patients in Florida, the nation’s third
largest state. The overall objective will be achieved by pursuing three specific aims.
(1) External and prospective validation of novel interpretable, dynamic, actionable, fair and reproducible
algorithmic toolkit for real-time surgical risk surveillance. (2) Developing and evaluating explainable AI platform
(XAI-IDEALIST) for real-time surgical risk surveillance using human-grounded benchmarks. (3) Implementing
and evaluating a federated learning approach with advanced privacy features for collaborative surgical risk
model training. The approach is innovative, because it represents the first attempt to (1) build the first surgical
FAIR (Findable, Accessible, Interoperable, Reproducible) AI-ready, large multicenter multimodal dataset, (2)
Novel computational approaches accompanied by assessing fairness and reproducibility, (3) a multifaceted
and full-stack explainable AI framework, and (4) federated learning capacity for privacy-preserving model
trainingacross institutions. The proposed research is significant since it will address several key problems and
critical barriers, including (1) lack of AI-ready large surgical datasets, (2) lack of interpretable, dynamic,
actionable, fair and reproducible surgical risk algorithms, (2) lack of a medical AI explainability platform, and (4)
lack of a systematic approach for collaborative model training and sharing across institutions. Ultimately, the
results are expected to improve patient outcomes and decrease hospitalization costs, as well as lifelong
complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10858694
-
项目类别:
-
资助金额:$637.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
Bridge2AI: Patient-Focused Collaborative Hospital Repository Uniting Standards (CHoRUS) for Equitable AI
-
批准号:10472824
-
项目类别:
-
资助金额:$588.03万
-
财政年份:2022
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10414976
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10594086
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10396041
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10609525
-
项目类别:
-
资助金额:$63.56万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10178157
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
-
批准号:10209005
-
项目类别:
-
资助金额:$56.22万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10154047
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10580785
-
项目类别:
-
资助金额:$60.06万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
-
批准号:10374834
-
项目类别:
-
资助金额:$59.49万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
-
批准号:10602426
-
项目类别:
-
资助金额:$55.72万
-
财政年份:2021
-
负责人:Azra Bihorac
-
依托单位:
Integrating data, algorithms and clinical reasoning for surgical risk assessment
-
批准号:9233163
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
Explainable, Fair, Reproducible and Collaborative Surgical Artificial Intelligence: Integrating data, algorithms and clinical reasoning for surgical risk assessment (XAI-IDEALIST)
-
批准号:10681418
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2016
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8280337
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8076251
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:8496075
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
PROMISES: Progenitor Endothelial Cells as a Marker of Endothelial Injury and Repa
-
批准号:7787562
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2010
-
负责人:Azra Bihorac
-
依托单位:
海外基金